Bicalutamide: A potential new oral antiandrogenic drug for female pattern hair loss-Reference-Cited by-同舟云学术

Bicalutamide: A potential new oral antiandrogenic drug for female pattern hair loss

Published:2020-11 Issue:5 Volume:83 Page:e355-e356
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Fernandez-Nieto Diego,Saceda-Corralo David,Jimenez-Cauhe Juan,Moreno-Arrones Oscar Muñoz,Rodrigues-Barata Rita,Hermosa-Gelbard Angela,Vano-Galvan Sergio

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. Safety of oral bicalutamide in female pattern hair loss: a retrospective review of 316 patients;Ferial Ismail;J Am Acad Dermatol,2020

2. Safety of antiandrogen therapy for treating prostate cancer;Ricci;Expert Opin Drug Saf,2014

3. Oral bicalutamide for female pattern hair loss: a pilot study;Fernandez-Nieto;Dermatol Ther,2019

4. Low-dose oral minoxidil for female pattern hair loss: a unicenter descriptive study of 148 women;Rodrigues-Barata;Skin Appendage Disord,2020

5. Combined oral contraception and bicalutamide in polycystic ovary syndrome and severe hirsutism: a double-blind randomized controlled trial;Moretti;J Clin Endocrinol Metab,2018

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bicalutamide: A review;Journal of Cutaneous and Aesthetic Surgery;2024-09-06

2. Mesotherapy with bicalutamide for female pattern hair loss;Indian Journal of Dermatology, Venereology and Leprology;2024-09-02

3. Bicalutamide in Dermatology: A Narrative Review;Indian Dermatology Online Journal;2024-08-30

4. Oral Supplementation with <sc>l</sc>-Cystine, Serenoa repens, Cucurbita pepo, and Pygeum africanum in Chronic Telogen Effluvium and Androgenetic Alopecia: A Double-Blind, Placebo-Controlled, Randomized Clinical Study;Skin Appendage Disorders;2024-07-26

5. Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies;Journal of Clinical Medicine;2024-05-23